Developing the first effective targeted therapy for the aggressive NRAS melanoma subtype

• Unité de recherche: INNOSUISSE
• Numéro de projet: 103.243.1 IP-LS
• Titre du projet anglais: Developing the first effective targeted therapy for the aggressive NRAS melanoma subtype

Description succincte (Allemand)

Developing the first effective targeted therapy for the aggressive NRAS melanoma subtype

Description succincte (Anglais)

Developing the first effective targeted therapy for NRAS melanoma

Résumé des résultats (Abstract) (Allemand)

Melanoma is the fifth most common cancer in Switzerland and the most lethal skin cancer. NRAS-mutated melanoma is the most aggressive subtype, with no effective therapy after immunotherapy failure. We will develop the first effective targeted therapy combination against this often fatal disease.

Résumé des résultats (Abstract) (Anglais)

Melanoma is the fifth most common cancer in Switzerland and the most lethal skin cancer. NRAS-mutated melanoma is the most aggressive subtype, with no effective therapy after immunotherapy failure. We will develop the first effective targeted therapy combination against this often fatal disease.